Recro Reports Second Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Recro Reports Second Quarter 2020 Financial Results

Recro Pharma (REPH) Misses Q2 EPS by 10c, Revenues Miss

August 10, 2020 7:09 AM EDT

Recro Pharma (NASDAQ: REPH) reported Q2 EPS of ($0.26), $0.10 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $15.52 million versus the consensus estimate of $18.88 million.

As the global COVID-19 situation continues to evolve, we have implemented new ways of working, and our concerns remain the health and safety of our associates, our customers, and the patients treated with the products we manufacture as well as our shareholders, said Gerri... More